The Source for Interventional
News and Education
In total, 12 experts felt the data were sufficient to recommend the claim for empagliflozin while 11 panel members voted against.
It’s impossible to say for sure whether the difference is due to disparities in care, since the study is observational, researcher cautions.
Even among the most high-risk patients, some might be willing to undergo TAVR if it provides meaningful improvements in quality of life, say experts.
Which hemodynamic support devices are used in your cath lab? (Select all that apply)